TABLE 1.
Genotype | n/Nb | Ref. allele | Alt. allele | CT18 position | Gene | Protein |
---|---|---|---|---|---|---|
3.5.4.1 | 96/96 | G | Ad | 3960783 | STY4102 | Putative l-lactate dehydrogenase |
G | Ad | 4794120 | gpmB | Probable phosphoglycerate mutase 2 | ||
3.5.4.2 | 77/77 | C | Td | 1731534 | STY1812 | Exodeoxyribonuclease III |
C | Td | 1945934 | STY2094 | Glucose 6-phosphate dehydrogenase | ||
3.5.4.3 | 106/107c | C | Te | 295362 | STY0278 | Putative drug efflux protein |
Genotype, suggested sublineage designation; n/N, number of S. Typhi isolates in Samoa over total number of S. Typhi isolates in the sublineage; Ref. allele, CT18 allele; Alt. allele, alternative SNP candidates in the genotype sublineage.
All SNPs were detected in 100% of their designated genotype groupings (N) and absent from 100% of out-grouped isolates (5,240 global S. Typhi genomes were analyzed).
One 3.5.4.3 isolate is of unknown origin.
Synonymous intragenic silent mutation.
Nonsynonymous intragenic missense mutation.